Buprenorphine physician–pharmacist collaboration in the management of patients with opioid use disorder: results from a multisite study of the National Drug Abuse Treatment Clinical Trials Network
Saved in:
Wu, L.T., et al., Buprenorphine physician–pharmacist collaboration in the management of patients with opioid use disorder: results from a multisite study of the National Drug Abuse Treatment Clinical Trials Network. Addiction, vol. 116, n. 7, 2021, p. 1805-1816.
Ref.
574455
Location:
SIIS Archivo (R.696)
Palabras clave:
Drogodependencias, Drogas ilegales, Opiáceos, Tratamiento, Intervención, Médicos, Farmacia, Recetas médicas, Fármacos, Buprenorfina, Programas de mantenimiento, Colaboración, Atención comunitaria, Efectos, Actitudes usuarios, Actitudes personal, Satisfacción, Evaluación de servicios, EE.UU.
Drogodependencias, Drogas ilegales, Opiáceos, Tratamiento, Intervención, Médicos, Farmacia, Recetas médicas, Fármacos, Buprenorfina, Programas de mantenimiento, Colaboración, Atención comunitaria, Efectos, Actitudes usuarios, Actitudes personal, Satisfacción, Evaluación de servicios, EE.UU.
Similar Items: Buprenorphine physician–pharmacist collaboration in the management of patients with opioid use disorder: results from a multisite study of the National Drug Abuse Treatment Clinical Trials Network
- Opioid treatment program and community pharmacy collaboration for methadone maintenance treatment: results from a feasibility clinical trial
- FACTORS ASSOCIATED WITH THE PRECRIBING OF BUPRENORPHINE OR METHADONE FOR TREATMENT OF OPIATE DEPENDENCE
- Pharmacy-based methadone treatment in the US: views of pharmacists and opioid treatment program staff
- THE PHARMACY PROFESSION'S REACTION TO SUBSTANCE ABUSE AMONG PHARMACISTS: THE PROCESS AND CONSEQUENCES OF MEDICALIZATION
- KNOWLEDGE, ATTITUDES AND PRACTICES OF PHARMACISTS CONCERNING PRESCRIPTION DRUG ABUSE
- EXPANDING TREATMENT CAPACITY FOR OPIOID DEPENDENCE WITH OFFICE BASED TREATMENT WITH BUPRENORPHINE: NATIONAL SURVEYS OF PHYSICIANS